Schubert & Co’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-51
Closed -$3.69K 48
2023
Q1
$3.69K Sell
51
-17
-25% -$1.32K ﹤0.01% 603
2022
Q4
$5.6K Sell
68
-13
-16% -$1.07K 0.01% 396
2022
Q3
$6K Buy
81
+29
+56% +$2.32K 0.01% 306
2022
Q2
$4K Buy
52
+33
+174% +$2.3K ﹤0.01% 400
2022
Q1
$1K Buy
19
+5
+36% +$290 ﹤0.01% 536
2021
Q4
$1K Buy
+14
New +$835 ﹤0.01% 492

Other funds holding ACHC

Schubert & Co's ACHC Position: Q2 2023 in Review

Schubert & Co sold out of Acadia Healthcare (ACHC) in Q2 2023, closing a stake of 51 shares — an estimated $3.69K sold.

Schubert & Co first reported a position in ACHC in Q4 2021 and held it in 6 quarters. The position peaked at $6K in Q3 2022. 280 funds tracked by Wall St. Rank hold ACHC as of Q2 2023.

  • Schubert & Co reported no remaining Acadia Healthcare position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 51 Acadia Healthcare shares in Q2 2023, an estimated $3.69K.
  • Schubert & Co first reported a position in Acadia Healthcare in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Acadia Healthcare position peaked at $6K in Q3 2022.
  • 280 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.